Nuveen Asset Management LLC Has $5.31 Million Stake in Amedisys, Inc. (NASDAQ:AMED)

Nuveen Asset Management LLC lessened its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 18.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,483 shares of the health services provider's stock after selling 13,223 shares during the quarter. Nuveen Asset Management LLC owned about 0.18% of Amedisys worth $5,310,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Blue Trust Inc. grew its position in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after buying an additional 124 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Amedisys during the 4th quarter worth approximately $55,000. Vestcor Inc acquired a new stake in shares of Amedisys during the 4th quarter worth approximately $73,000. Venturi Wealth Management LLC grew its position in shares of Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after buying an additional 779 shares during the period. Finally, Covestor Ltd grew its position in shares of Amedisys by 48.8% during the 4th quarter. Covestor Ltd now owns 1,037 shares of the health services provider's stock worth $94,000 after buying an additional 340 shares during the period. Institutional investors and hedge funds own 94.36% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on AMED. Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th. Finally, Stephens reaffirmed an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research note on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $100.75.

Amedisys Stock Up 0.1%

Shares of AMED stock traded up $0.08 during trading on Wednesday, reaching $94.57. The company's stock had a trading volume of 367,543 shares, compared to its average volume of 410,497. The business has a fifty day moving average price of $93.59 and a 200-day moving average price of $91.66. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The company has a market cap of $3.10 billion, a price-to-earnings ratio of 37.53, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. The business had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 earnings per share. Analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.